Danske Bank’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-700
Closed -$64.1K – 1349
2025
Q4
$64.1K Sell
700
-12,409
-95% -$1.19M ﹤0.01% 902
2025
Q3
$1.24M Sell
13,109
-4,899
-27% -$461K ﹤0.01% 643
2025
Q2
$1.89M Sell
18,008
-3,134
-15% -$297K ﹤0.01% 605
2025
Q1
$1.87M Buy
21,142
+270
+1% +$27.7K 0.01% 687
2024
Q4
$2M Sell
20,872
-53,005
-72% -$4.94M 0.01% 657
2024
Q3
$6.05M Sell
73,877
-9,824
-12% -$758K 0.02% 523
2024
Q2
$7.22M Buy
83,701
+61,557
+278% +$4.97M 0.03% 441
2024
Q1
$1.81M Buy
+22,144
New +$1.73M 0.01% 712

Other funds holding HQY

Danske Bank's HQY Position: Q1 2026 in Review

Danske Bank sold out of HealthEquity (HQY) in Q1 2026, closing a stake of 700 shares — an estimated $64.1K sold.

Danske Bank first reported a position in HQY in Q1 2024 and held it in 8 quarters. The position peaked at $7.22M in Q2 2024. 487 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Danske Bank reported no remaining HealthEquity position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 700 HealthEquity shares in Q1 2026, an estimated $64.1K.
  • Danske Bank first reported a position in HealthEquity in Q1 2024 and held it in 8 quarters.
  • Danske Bank's HealthEquity position peaked at $7.22M in Q2 2024.
  • 487 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.